In contrast , RB1 status did not affect sensitivity of TNBC cells to multiple other drugs including cisplatin ( CDDP ) , 5-fluorouracil , idarubicin , epirubicin , PRIMA-1 ( met ) , fludarabine and PD-0332991 , some of which are used to treat TNBC patients .